Italia markets closed

HRMY Jul 2024 12.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,10000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1000
Aperto0,1000
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio12,50
Scadenza2024-07-19
Min-Max giorno0,1000 - 0,1000
Contratto - Min-MaxN/D
Volume2
Open Interest3
  • GlobeNewswire

    Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates

    WAKIX® (pitolisant) Net Revenue Increased ~25% Year-over-Year to $134.2 Million for Second Quarter 2023 Average Number of Patients on WAKIX Increased by ~350 Sequentially to ~5,450 for Second Quarter 2023 Exited Second Quarter 2023 With ~5,600 Patients on WAKIX Completed Enrollment in Phase 3 Idiopathic Hypersomnia (IH) INTUNE Study; On-track for Topline Data in Fourth Quarter 2023 Plans to Initiate Prader-Willi Syndrome (PWS) Phase 3 Study in Fourth Quarter 2023 Board of Directors Authorized $1